CNO Financial Group, Inc.

As of September 8, 2025, CNO Financial Group's trend is neutral with mixed signals, showing mild bullishness in the weekly MACD and Bollinger Bands, but some weakness in daily moving averages and OBV, while it has outperformed the S&P 500 recently but lags in long-term performance.

As of June 30, 2025, CNO Financial Group, Inc. is fairly valued with a P/E ratio of 13, a competitive EV to EBITDA ratio of 12.49, a high dividend yield of 188.88%, and has outperformed the S&P 500 over the past month and three years.

As of June 27, 2025, the trend is bullish overall, supported by monthly indicators, despite a mildly bearish outlook on the weekly charts, indicating some short-term caution.

As of June 5, 2025, CNO Financial Group, Inc. shows a mildly bullish trend, supported by daily moving averages and monthly indicators, despite some bearish signals on the weekly timeframe.

As of April 28, 2025, CNO Financial Group, Inc. is fairly valued with a P/E ratio of 13, an EV to EBITDA of 12.49, and a notable dividend yield of 188.88%, while outperforming the S&P 500 with a 38.53% return over the past year.

As of March 2022, the management team of CNO Financial Group, Inc. includes Mr. Daniel Maurer (Independent Chairman), Mr. Gary Bhojwani (CEO), and several independent directors: Mr. Steven Shebik, Ms. Ellyn Brown, Mr. Stephen David, Mr. David Foss, and Mr. Robert Greving. They are responsible for the company's strategic direction and governance.

CNO Financial Group, Inc. is a holding company for insurance firms that offers health insurance, annuities, and individual life insurance products. As of March 2025, it has a market cap of $3.66 billion and a net profit of $14 million.

As of Jun 18, CNO Financial Group, Inc. has a market capitalization of $3.66 billion, with shareholder's funds of $2.50 billion and total assets of $34.22 billion.